Kadmon Holdings, Inc. 3 SEC Filings

Filed On	Filing
13 Aug 2020	Form 3: Miller-Rich Nancy, Director No securities owned
30 Aug 2019	Form 3: Moss Gregory S., EVP, General Counsel Holds 1,964 shares of Common stock, par value $0.001
16 May 2019	Form 3: Kirsch Arthur S, Director No securities owned
07 Feb 2019	Form 3: Cohen David E, Director No securities owned
23 Jan 2019	Form 3: Schwalm Cynthia, Director No securities owned
08 Jan 2019	Form 3: Vivo Capital VIII, Llc, 10% owner and 4 others Holds 3,195,151 shares of Common Stock
29 Oct 2018	Form 3: Carver Kyle, Principal Accounting Officer Holds 581 shares of Common Stock, par value $0.001
22 Jun 2018	Form 3: Perceptive Advisors Llc, 10% owner and 2 others Holds 13,165,746 shares of Common Stock
20 Mar 2017	Form 3: Edelman Joseph, 10% owner Holds 4,955,474 shares of Common Stock
17 Feb 2017	Form 3: Konidaris Tasos, Director No securities owned
26 Jan 2017	Form 3: Meehan Steven, Director No securities owned
26 Jul 2016	Form 3: Cohen Andrew B, Director Holds 98,040 shares of Common Stock, par value $0.001
26 Jul 2016	Form 3: Goldentree Asset Management Lp, 10% owner and 3 others Holds 174,255 shares of Common Stock, par value $0.001 ("Common Stock")
26 Jul 2016	Form 3: Forbes Alexandria, Director Holds 770 shares of Common Stock, par value $0.001
26 Jul 2016	Form 3: Bauer Eugene, Director Holds 1,716 shares of Common Stock, par value $0.001
26 Jul 2016	Form 3: Loeb Daniel S, 10% owner and 1 other Holds 6,113,020 shares of Common Stock
26 Jul 2016	Form 3: Zhu Zhenping, Executive VP Biologics Holds 18,462 shares of Common Stock, par value $0.001
26 Jul 2016	Form 3: Zan Shengda, Director Holds 412,299 shares of Common Stock, par value $0.001
26 Jul 2016	Form 3: Wiviott Susan, Director Holds 4,168 shares of Common Stock, par value $0.001
26 Jul 2016	Form 3: Kadmon I, Llc, 10% owner Holds 5,450,273 shares of Common Stock

Comments